Funded Projects › HORIZON
HYDROHEAL · Multi-functional hydrogels for promoting bone fracture healing through local induced release of pharmaceutical agents and gradual matrix replacement by the regenerating bone
Bone atrophy and fractures, resulting from trauma, infections, osteoporosis, or cancer, are global health concerns. Standard care with cement and bone grafts has limitations. Synthetic polymers like polymethyl methacrylate risk leakage, spinal issues, and poor healing. Donor shortages for allogenic bone grafting and invasive procedures pose risks such as rejection and viral transmission. HYDROHEAL innovates with hydrogel formulations to address bone strength challenges by treating vertebral and alveolar fractures.HYDROHEAL aims to develop safe, sustainable scaling, and cost-effective formulations using renewable biomaterials for targeted drug delivery, aligning closely with the EU Circular Economy Action Plan and Chemicals Strategy for Sustainability. It is ready to introduce a new era in fracture therapy. The proposed self-solidifying hydrogels release active pharmaceutical ingredients locally upon external stimulation, potentially improving treatment efficacy, preventing infections, and speeding up fracture healing.The objectives of the project are:1. Develop novel injectable hydrogel formulations combining natural substance derivates to enhance healing, inhibit bacterial growth, and monitor therapy progress in vivo.2. Simultaneously manufacture carriers as micro- and nano-particles, surface-functionalized to incorporate pharmaceutical agents, releaseable upon external stimuli for tailored drug release.3. Validate safe and optimized hydrogel formulations for treating vertebral and alveolar bone fractures through in vitro and in vivo tests.4. Demonstrate scalable and sustainable biomaterial manufacturing through safe design methods, machine learning, and predictive life cycle assessment.5. Develop machine learning and hybrid digital modeling methods, combining adaptive design of experiments and physics-based modeling with advanced characterization techniques.
Consortium · 13 organisations
UNIVERSITAT POLITECNICA DE VALENCIA
ES · €891,824
CONSULTECH TECHNOLOGIEBERATUNG GMBH
DE · €391,082
CENTRE FOR PROCESS INNOVATION LIMITED LBG
UK · €893,771
UNIVERSITY OF NEWCASTLE UPON TYNE
UK · €407,245
UNIVERSITAT POLITECNICA DE CATALUNYA
ES · €499,816
Separeco Srl
IT · €176,407
VET EX MACHINA LIMITED
CY · €401,100
SITEC PHARMABIO SL
ES · €424,994
POLITECNICO DI TORINO
IT · €787,625
FLUIDINOVA SA
PT · €168,371
UNIVERSITY OF WARWICK
UK · €799,860
ASPHALION SL
ES · €195,563
ROYAL COLLEGE OF SURGEONS IN IRELAND
IE · €416,084
Research fields
← Find collaborators and more funded projects
Source: CORDIS, Publications Office of the European Union. Global Research Partnerships surfaces open EU research data to help you find collaborators; we are not affiliated with the European Union.